Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France. As of 2014, it has become the world’s fourth-largest pharmaceutical company by sales. The company was formed as Sanofi-Aventis in 2004 by the merger of Aventis and Sanofi-Synthélabo, which were each the product of several previous mergers. It changed its name to Sanofi in May 2011.
Sanofi is a global healthcare leader focused on patient’s needs, engaged in research, development, manufacturing and marketing of health products, with a diversified offer of medicines, vaccines and innovative therapeutic solutions. The company covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines (it is the world’s largest producer of the latter through its subsidiary Sanofi Pasteur). It has presence in over 100 countries worldwide with more than 110,000 of workforce. Sanofi has 110 industrial sites and more than 20 research and development sites all over the world making it a major player in pharmaceutical industry.
- Human Vaccine
- Multiple Sclerosis
- Consumer Healthcare
|Traded as||Euronext: SAN
|Founded||20 August 2004 (by acquisition) as Sanofi Aventis
6 May 2011 as Sanofi
|Key people||Olivier Brandicourt (CEO, Chairman)
Jean-François Dehecq (Original Founder)
|Products||Prescription and over-the-counter drugs for thrombosis, cardiovascular disease, diabetes, central nervous system disorders, oncology and internal medicine, vaccines|
|Revenue||€33.77 billion (2014)|
|Net income||€6.14 billion (2014)|
|Number of employees||112,128 (2013)|